Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant

Summary

This randomized phase II trial studies the side effects and how well melphalan hydrochloride works in treating patients with multiple myeloma that has come back or does not respond to treatment. Drugs used in chemotherapy, such as melphalan hydrochloride, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Timeline

Start

2018-09-01

Primary completion

2021-03-31

Completion

2021-03-31

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications